Becton Dickinson and Company (BDX) support and resistance · P/E 34, rev $21.84B
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
This page maps Becton Dickinson and Company (BDX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BDX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BDX quote page for the session range and the stock page for the full model.
Not investment advice.